Aurobindo Pharma arm announces successful Phase 1 clinical study outcome of their BP11 product Susmita Roy18 March 2024 1:30 PM ISTHyderabad: CuraTeQ Biologics Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, has announced that their Omalizumab biosimilar...
Lupin gets one USFDA observation for Aurangabad facility Ruchika Sharma18 March 2024 12:20 PM ISTMumbai: Lupin has announced that the Company received Form-483 with one observation from the US Food and Drug Administration (USFDA) at the...
Zydus Lifesciences gets USFDA okay for Finasteride and Tadalafil Capsules Susmita Roy18 March 2024 11:52 AM ISTTadalafil is used to treat benign prostatic hyperplasia.
Syngene biologics manufacturing facility to be operational for US, European customers from mid year Ruchika Sharma18 March 2024 10:00 AM ISTBangalore: At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International, a global contract research, development and...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal For Study of SAR443122 in Ulcerative Colitis Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Need More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: Citing that more justification is required, the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Modify Clinical study protocol of Iptacopan study in aHUS: CDSCO Panel Tell Novartis Dr. Divya Colin17 March 2024 5:15 PM ISTNew Delhi: Reviewing the Phase IIIb clinical trial study protocol of Iptacopan, the Subject Expert Committee (SEC) functional under the Central...
Ionis announces positive results from Phase 2 study of ION224 to treat NASH/MASH Kajal Rajput17 March 2024 5:00 PM ISTNew Delhi: Ionis Pharmaceuticals announced positive results from a Phase 2 study of ION224, an investigational DGAT2 antisense inhibitor in...
Bayer, Aignostics to collaborate on next generation precision oncology Ruchika Sharma17 March 2024 10:00 AM ISTBerlin: Bayer and Aignostics GmbH have announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with...
CDSCO Panel Grants Roche's Protocol Amendment Proposal For Crovalimab study Dr. Divya Colin16 March 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Biocon CFO Indranil Sen Resigns Divyani Paul16 March 2024 2:46 PM ISTBangalore- Indranil Sen, Chief Financial Officer (CFO) of Bengaluru-based Indian biopharmaceutical company Biocon, has resigned from his post...
